Company Analysis
Sign in

HeartSciences Inc. (HSCS)

Nasdaq: HSCS · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Southlake, TX · filing with the SEC since 2009
Full chart Alerts Compare
Grade3.4
◀ Past 2.6● Present 2.5▶ Future 5.3
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in April.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Period endingApr 30, 2026Apr 30, 2025Apr 30, 2024Apr 30, 2023Apr 30, 2022
Report filedJul 23, 2026Jul 24, 2025Jul 29, 2024Jul 19, 2023Jul 29, 2022
Revenue4,3194,35018,6005,15014,373
Cost of revenue1,7681,8806,0812,7967,890
Gross profit2,5512,47012,5192,3546,483
Research and development2,839,0124,386,1052,878,5542,460,8683,001,532
Selling, general and administrative5,576,4063,968,9363,439,7353,654,4501,714,350
Total operating expenses8,415,4188,355,0416,318,2896,115,3184,715,882
Operating income-8,412,867-8,352,571-6,305,770-6,112,964-4,709,399
Interest expense753,041500,453354,080243,174371,619
Other income (expense), net24,03387,795···
Total non-operating income (expense)-729,008-412,658-299,438-241,326-118,861
Income tax expense00···
Net income-9,141,875-8,765,229-6,605,208-6,354,290-4,828,260
Earnings per share, basic-3.48-9.34-18.74r-80.00r-145.00b
Earnings per share, diluted·-9.34-18.74r-80.00r-145.00b
Weighted average shares, basic2,625,421938,257352,52079,506r33,189b
Weighted average shares, diluted·938,257352,52079,506r33,189b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-100 reverse split of Oct 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton HSCS · research, not advice